4MH7
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1896
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-06-13 |
Detector | MARMOSAIC 300 mm CCD |
Wavelength(s) | 0.97921 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 50.874, 90.864, 69.587 |
Unit cell angles | 90.00, 99.98, 90.00 |
Refinement procedure
Resolution | 32.060 - 2.510 |
R-factor | 0.2283 |
Rwork | 0.223 |
R-free | 0.27930 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3brb |
RMSD bond length | 0.003 |
RMSD bond angle | 0.659 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: dev_1468)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 32.060 | 2.530 |
High resolution limit [Å] | 2.510 | 2.510 |
Rmerge | 0.125 | 0.564 |
Number of reflections | 20799 | |
<I/σ(I)> | 10.7 | 2.2 |
Completeness [%] | 97.7 | 81.1 |
Redundancy | 4.1 | 3.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 288 | Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500mM sodium chloride, 2mM beta-mercaptoethanol, incubated with inhibitor (2.5 mM final concentration) overnight, mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), VAPOR DIFFUSION, SITTING DROP, temperature 288K |